JPET xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Phillips, B. M.
Right arrow Articles by Yim, G. K. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Phillips, B. M.
Right arrow Articles by Yim, G. K. W.
Journal of Pharmacology And Experimental Therapeutics, Vol. 135, Issue 2, 223-229, 1962
Copyright © 1962 by American Society for Pharmacology and Experimental Therapeutics


STUDIES ON THE MECHANISM OF MEPROBAMATE TOLERANCE IN THE RAT

Barrie M. Phillips 1, Tom S. Miya 1, and George K. W. Yim 1

1 Department of Pharmacology, Purdue University, West Lafayette, Indiana

The development of tolerance to meprobamate in rats was investigated by the measurement of whole body activity before and after the administration of meprobamate to meprobamate-pre-treated and control animals. The results indicate that tolerance to meprobamate does develop in rats following the daily administration of meprobamate for 35 days.

Further studies revealed that after reaching essentially the same levels initially in both tolerant and nontolerant rats, the brain and blood C14 levels, representative of unchanged meprobamate, as well as fat and muscle C14 levels, decreased at a more rapid rate in tolerant than in nontolerant animals. It was also observed that urinary excretion in tolerant rats was more rapid at early time intervals than in nontolerant animals, although the total amount excreted by both groups in 24 hours was essentially the same. Metabolite studies demonstrated that nontolerant animals excreted nearly twice as much unchanged meprobamate as tolerant rats. These findings demonstrate that increased metabolic inactivation plays an important role in the development of meprobamate tolerance.

Submitted on July 17, 1961







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1962 by the American Society for Pharmacology and Experimental Therapeutics.